MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Basal ganglia"

  • 2024 International Congress

    Matrix in the Classroom: Augmented Reality’s Role in the Transformation of Neuroanatomy Education

    J. Brainer, A. Fox, P. Brainer, P. Brainer, A. Brainer (Recife, Brazil)

    Objective: This study aims to assess the impact of a novel virtual reality platform on the teaching of clinical neuroanatomy to students in health-related fields.…
  • 2024 International Congress

    Cortical and Subcortical Brain Volume Changes in Idiopathic REM Sleep Disorder Subjects at Risk for Parkinson’s Disease

    M. Lima Gregorio, B. Renner, Z. Fan, E. Hogg, C. Malatt, E. Tan, M. Kelly, R. Artal, P. Sati, M. Tagliati (Los Angeles, USA)

    Objective: To quantify cortical and subcortical brain volumes using structural MRI analysis in idiopathic REM sleep behavior disorder (iRBD) subjects at risk for Parkinson`s disease…
  • 2024 International Congress

    Abnormal basal ganglia-related functional gradient in Parkinson’s disease

    L. Chen, L. Sun, M. Xia, T. Wu (Beijing, China)

    Objective: The aim of this research was to investigate the basal ganglia (BG)-related functional gradient alterations and the association between these brain dysfunctions and clinical…
  • 2024 International Congress

    Comparison of Spontaneous Brain Activity in Distinguishing Parkinsonian Variant of Multiple System Atrophy from Parkinson’s Disease at Early Stage

    S. Wang, Y. Xiao, Y. Hou, C. Li, L. Zhang, R. Ou, Q. Wei, J. Lin, T. Yang, N. Che, Q. Jiang, X. Zheng, J. Liu, H. Shang (Chengdu, China)

    Objective: The primary objective was to explore distinctions in the fractional amplitude of low-frequency fluctuation (fALFF) indicator among early-stage parkinsonian variant of multiple system atrophy…
  • 2024 International Congress

    Severity of Motor Symptoms Correlates with Asymmetric Changes in Globus Pallidus Internus and Caudate Nuclei in Parkinson’s Disease

    J. Martinez-Lemus, E. Tharp, T. Ellmore, C. Adams, R. Abuamouneh, E. Rodarte, M. Schiess (Houston, USA)

    Objective: Explore the relationship between MDS-UPDRS motor sub-scores (MDS-UPDRS-III) and cerebral perfusion in different Regions of Interest (ROI) in patients with Parkinson’s disease (PwP). Background:…
  • 2024 International Congress

    Is acute dystonia in a teenager psychogenic dystonia?

    G. Ilina, D. Khasanova, Z. Zalyalova, A. Lestrovaya (Kazan, Russian Federation)

    Objective: To compare literature data on psychogenic tremor and clinical and MRI data of the patient. Background: Dystonia is a involuntary, sustained or repetitive, patterned…
  • 2024 International Congress

    Phenotypic Aspects of Huntington’s Disease-Like 2 in Brazil and the World: Literature Review

    D. Boone, M. Costa, C. Silva, L. Barcelos, B. Veiga, R. Pinto, P. Aguiar, S. Azevedo, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To describe the known phenotypic profile of HDL2 patients currently described in the literature. Background: HDL2 is an autosomal dominant neurodegenerative disorder caused by…
  • 2024 International Congress

    Chronic striatal cholinergic agonist infusion as a model of dystonia

    E. Courtin, B. Ribot, M. Deffains, D. Guehl, P. Burbaud (Bordeaux, France)

    Objective: The objectives of this work were to create a primate model of dystonia based on striatal infusion of a muscarinic agonist (oxotremorin), and to…
  • 2024 International Congress

    GABA in the Basal Ganglia Tracks Motor Severity and Response to BoNT Treatment in Cervical Dystonia

    C. Dintino, C. Groth, B. Berman (Richmond, USA)

    Objective: Determine if GABA and glutamate levels within sensorimotor network nodes correlate with symptom severity in cervical dystonia (CD) and are altered by botulinum neurotoxin…
  • 2024 International Congress

    Writing dysfluency associates with basal ganglia network dysfunction in writer’s cramp dystonia

    N. Bukhari-Parlakturk, P. Mulcahey, M. Fei, M. Lutz, J. Voyvodic, S. Davis, A. Michael (Durham, USA)

    Objective: The primary objective of this study was to identify brain regions associated with behavioral measures of dystonia in a specific subtype called writer’s cramp…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley